Non-immunosuppressive Cyclosporin Debio-025 with Interferon shows synergistic Anti-HCV Effect in Chimeric Mouse | Debio 025 | /

Home|Careers|Contact us

News

20.11.2008
Debiopharm and Aurigene sign licensing agreement for the development and commercialisation of Debio 0617, a novel inhibitor of an undisclosed oncology pathway
17.11.2008
Debiopharm and Pharmaleads sign license agreement for Debio 0827 or PL37 in treatment of chronic pain conditions

Non-immunosuppressive Cyclosporin Debio-025 with Interferon shows synergistic Anti-HCV Effect in Chimeric Mouse

K. Inoue, T. Umehara, T. Watanabe, J.M. Dumont, P. Scalfaro, M. Yoshiba, H. Kohara

57th Annual Meeting of the American Association for the Study of Liver Diseases (AASLD) - Oct 2006 - Boston/USA (Abstract)